Chapter: 1. INTRODUCTION
1.1. Report description
1.2. Key benefits
1.3. Key market segments
1.4. Research methodology
1.4.1. Secondary research
1.4.2. Primary research
1.4.3. Analyst tools and models
Chapter: 2. EXECUTIVE SUMMARY
2.1. Key findings of the study
2.2. CXO perspective
Chapter: 3. MARKET OVERVIEW
3.1. Market definition and scope
3.2. Key findings
3.2.1. Top investment pockets
3.2.2. Top winning strategies
3.2.2.1. Competitive intelligence of companies and their strategies
3.3. Porters five forces analysis
3.3.1. Bargaining power of the suppliers
3.3.2. Bargaining power of buyers
3.3.3. Threat of new entrants
3.3.4. High intensity of rivalry
3.3.5. Threat of substitutes
3.4. Top Player Positioning, 2015
3.5. Market dynamics
3.5.1. Drivers
3.5.1.1. Growing elderly population and rise in prevalence of chronic diseases
3.5.1.2. Technological advancements in the field of implantable medical devices
3.5.1.3. Global rise in acceptance of implantable medical devices
3.5.1.4. Improvement of healthcare infrastructure in developing countries
3.5.1.5. Better insurance and reimbursement
3.5.1.6. Increasing government focus on funding R&D initiatives
3.5.1.7. Rising number of FDA approvals for performing clinical trials to benefit the market
3.5.2. Restraints
3.5.2.1. High cost of treatment associated with implantable medical devices
3.5.2.2. Stringent approval process as these are highly specialized devices
3.5.3. Opportunities
3.5.3.1. Huge market opportunities in the APAC region and developing countries
3.5.3.2. Increasing awareness amongst patients and increasing preference for a better quality of life
3.5.3.3. Increase in development of minimally invasive and non-surgical procedures
Chapter: 4. WORLD IMPLANTABLE MEDICAL DEVICES MARKET, BY PRODUCT
4.1. Overview
4.1.1. Market size and forecast
4.2. Orthopedic implants
4.2.1. Key market trends
4.2.2. Key growth factors and opportunities
4.2.3. Market size and forecast
4.2.4. Reconstructive joint replacements market size and forecast
4.2.5. Spinal implants market size and forecast
4.3. Cardiovascular implants
4.3.1. Key market trends
4.3.2. Key growth factors and opportunities
4.3.3. Market size and forecast
4.4. Intraocular lenses
4.4.1. Key market trends
4.4.2. Key growth factors and opportunities
4.4.3. Market size and forecast
4.5. Dental implants
4.5.1. Key market trends
4.5.2. Key growth factors and opportunities
4.5.3. Market size and forecast
4.6. Breast implants
4.6.1. Key market trends
4.6.2. Key growth factors and opportunities
4.6.3. Market size and forecast
4.7. Other implants
4.7.1. Key market trends
4.7.2. Key growth factors and opportunities
4.7.3. Market size and forecast
Chapter: 5. WORLD IMPLANTABLE MEDICAL DEVICES MARKET, BY REGION
5.1. Overview
5.1.1. Market size and forecast
5.2. North America
5.2.1. Key market trends
5.2.2. Key growth factors and opportunities
5.2.3. Market size and forecast
5.2.4. U.S. market size and forecast
5.2.5. Canada market size and forecast
5.2.6. Mexico market size and forecast
5.3. Europe
5.3.1. Key market trends
5.3.2. Key growth factors and opportunities
5.3.3. Market size and forecast
5.3.4. Germany market size and forecast
5.3.5. France market size and forecast
5.3.6. UK market size and forecast
5.3.7. Rest of Europe market size and forecast
5.4. Asia-Pacific
5.4.1. Key market trends
5.4.2. Key growth factors and opportunities
5.4.3. Market size and forecast
5.4.4. Japan market size and forecast
5.4.5. China market size and forecast
5.4.6. India market size and forecast
5.4.7. Rest of Asia-Pacific market size and forecast
5.5. LAMEA
5.5.1. Key market trends
5.5.2. Key growth factors and opportunities
5.5.3. Market size and forecast
5.5.4. Latin America market size and forecast
5.5.5. Middle East market size and forecast
5.5.6. Africa market size and forecast
Chapter: 6. COMPANY PROFILES
6.1. Abbott Laboratories
6.1.1. Company overview
6.1.2. Operating business segments
6.1.3. Business performance
6.1.4. Key strategic moves & developments
6.1.5. SWOT analysis
6.2. Biotronik SE & Co. KG
6.2.1. Company overview
6.2.2. Operating business segments
6.2.3. Key strategic moves & developments
6.2.4. SWOT analysis
6.3. Boston Scientific Corporation
6.3.1. Company overview
6.3.2. Operating business segments
6.3.3. Business performance
6.3.4. Key strategic moves & developments
6.3.5. SWOT analysis
6.4. C. R. Bard, Inc.
6.4.1. Company overview
6.4.2. Operating business segments
6.4.3. Business performance
6.4.4. Key strategic moves & developments
6.4.5. SWOT analysis
6.5. Cardinal Health, Inc.
6.5.1. Company overview
6.5.2. Operating business segments
6.5.3. Business performance
6.5.4. Key strategic moves & developments
6.5.5. SWOT analysis
6.6. Conmed Corporation
6.6.1. Company overview
6.6.2. Operating business segments
6.6.3. Business performance
6.6.4. SWOT analysis
6.7. Globus Medical, Inc.
6.7.1. Company overview
6.7.2. Operating business segments
6.7.3. Business performance
6.7.4. Key strategic moves & developments
6.7.5. SWOT analysis
6.8. Integra Lifesciences Holdings Corporation
6.8.1. Company overview
6.8.2. Operating business segments
6.8.3. Business performance
6.8.4. Key strategic moves & developments
6.8.5. SWOT analysis
6.9. Johnson & Johnson
6.9.1. Company overview
6.9.2. Operating business segments
6.9.3. Business performance
6.9.4. Key strategic moves & developments
6.9.5. SWOT analysis
6.10. LivaNova PLC
6.10.1. Company overview
6.10.2. Operating business segments
6.10.3. Business performance
6.10.4. Key strategic moves & developments
6.10.5. SWOT analysis
6.11. Medtronic plc
6.11.1. Company overview
6.11.2. Operating business segments
6.11.3. Business performance
6.11.4. Key strategic moves & developments
6.11.5. SWOT analysis
6.12. Nuvasive, Inc.
6.12.1. Company overview
6.12.2. Operating business segments
6.12.3. Business performance
6.12.4. Key strategic moves & developments
6.12.5. SWOT analysis
6.13. Smith & Nephew Plc
6.13.1. Company overview
6.13.2. Operating business segments
6.13.3. Business performance
6.13.4. Key strategic moves & developments
6.13.5. SWOT analysis
6.14. St. Jude Medical, Inc.
6.14.1. Company overview
6.14.2. Operating business segments
6.14.3. Business performance
6.14.4. Key strategic moves & developments
6.14.5. SWOT analysis
6.15. Institut Straumann AG.
6.15.1. Company overview
6.15.2. Business performance
6.15.3. Key strategic moves & developments
6.15.4. SWOT analysis
6.16. Stryker Corporation
6.16.1. Company overview
6.16.2. Operating business segments
6.16.3. Business performance
6.16.4. Key strategic moves & developments
6.16.5. SWOT analysis
6.17. Wright Medical Group N.V.
6.17.1. Company overview
6.17.2. Operating business segments
6.17.3. Business performance
6.17.4. Key strategic moves & developments
6.17.5. SWOT analysis
6.18. Zimmer Biomet Holdings, Inc.
6.18.1. Company overview
6.18.2. Operating business segments
6.18.3. Business performance
6.18.4. Key strategic moves & developments
6.18.5. SWOT analysis